Cencora Inc. (COR) Q1 2026 (USD) EPS 4.08 (exp. 4.05), Revenue 85.9bln (exp. 86.06bln); FY Outlook: Adj. EPS 17.45-17.75 (exp. 17.61)
Importance
Level 1
FY guidance:
- Adjusted operating income guidance has been raised to growth of 11.5% to 13.5% (prev. 8% to 10%) primarily to reflect the completion of the acquisition of OneOncology and the performance of the U.S. Healthcare Solutions segment.
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#CORESITE REALTY CORP#COR.US#FOREX#EQUITIES#METALS#EU SESSION#HEALTH CARE DISTRIBUTORS#METALS & MINING#HEALTH CARE PROVIDERS & SERVICES#HEALTH CARE EQUIPMENT & SERVICES (GROUP)#S&P 500 INDEX#CENCORA INC#COR#DXY#US EQUITIES